• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Reengineered tricyclic anti-cancer agents" [Bioorg. Med. Chem. 23 (2015) 6528-6534].

作者信息

Kastrinsky David B, Sangodkar Jaya, Zaware Nilesh, McClinch Kimberly, Farrington Caroline C, Giannini Heather M, Izadmehr Sudeh, Dhawan Neil S, Narla Goutham, Ohlmeyer Michael

机构信息

Department of Structural and Chemical Biology, Icahn School of Medicine at Mt. Sinai, 1425 Madison Avenue, New York, NY 10029, United States.

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mt. Sinai, 1425 Madison Avenue, New York, NY 10029, United States.

出版信息

Bioorg Med Chem. 2015 Dec 1;23(23):7487. doi: 10.1016/j.bmc.2015.11.002. Epub 2015 Nov 9.

DOI:10.1016/j.bmc.2015.11.002
PMID:28290285
Abstract
摘要

相似文献

1
Corrigendum to "Reengineered tricyclic anti-cancer agents" [Bioorg. Med. Chem. 23 (2015) 6528-6534].《“重新设计的三环抗癌剂”的勘误》[《生物有机与药物化学》23 (2015) 6528 - 6534]
Bioorg Med Chem. 2015 Dec 1;23(23):7487. doi: 10.1016/j.bmc.2015.11.002. Epub 2015 Nov 9.
2
Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].对《McN - 5652的结构》[《生物有机与药物化学》9 (2001) 2105]及《McN - 5652的结构》勘误[《生物有机与药物化学》10 (2002) 3368]的述评
Bioorg Med Chem. 2002 Oct;10(10):3367. doi: 10.1016/s0968-0896(02)00113-x.
3
Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419].
Bioorg Med Chem. 2019 Sep 1;27(17):3960-3961. doi: 10.1016/j.bmc.2019.07.018. Epub 2019 Jul 22.
4
Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].《查耳酮衍生物作为抗炎剂的设计、合成、生物学评价及分子对接》的勘误 [《生物有机与药物化学快报》27 (3) (2017) 602 - 606]
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3822. doi: 10.1016/j.bmcl.2018.10.027. Epub 2018 Oct 30.
5
Corrigendum to "Evolvosides C-E, flavonol-4'-O-triglycosides from Evolvulus alsinoides and their anti-stress activity" [Bioorg. Med. Chem. 21 (2013) 1116-1122].《关于“旋花甙C - E，来自鲫鱼胆草的黄酮醇 - 4'-O - 三糖苷及其抗应激活性”的勘误》[《生物有机与药物化学》21 (2013) 1116 - 1122]
Bioorg Med Chem. 2013 Apr 15;21(8):2426. doi: 10.1016/j.bmc.2013.02.031. Epub 2013 Mar 6.
6
Corrigendum to "Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types" [Bioorg. Med. Chem. 27 (1) (2019) 208-215].《新型辣椒素类似物的合成及其构效关系研究：对多种癌症类型具有显著抗癌作用》[《生物有机与药物化学》27 (1) (2019) 208 - 215]的勘误
Bioorg Med Chem. 2019 Jun 1;27(11):2280. doi: 10.1016/j.bmc.2019.04.007. Epub 2019 Apr 20.
7
Corrigendum to "Synthesis and biological evaluations of new nitric oxide-anti-inflammatory drug hybrids" [Bioorg Med Chem Lett (2017) 4358-4369].
Bioorg Med Chem Lett. 2018 Feb 15;28(4):839. doi: 10.1016/j.bmcl.2018.01.024. Epub 2018 Jan 31.
8
Corrigendum to "Anti-cancer potential of (1,2-dihydronaphtho[2,1-b]furan-2-yl)methanone derivatives" [Bioorg. Med. Chem. Lett. 30 (2020) 127476].《(1,2-二氢萘并[2,1-b]呋喃-2-基)甲酮衍生物的抗癌潜力》勘误 [《生物有机与药物化学快报》30 (2020) 127476]
Bioorg Med Chem Lett. 2021 Feb 15;34:127764. doi: 10.1016/j.bmcl.2020.127764. Epub 2021 Jan 2.
9
Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
Bioorg Med Chem Lett. 2017 May 1;27(9):2081. doi: 10.1016/j.bmcl.2017.02.064. Epub 2017 Mar 20.
10
Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477].《“1-噻唑-2-基-N-3-甲基-1H-吡唑-5-羧酸衍生物作为抗肿瘤剂”的勘误》[《生物有机与药物化学快报》27 (2017) 4471 - 4477]
Bioorg Med Chem Lett. 2018 Mar 1;28(5):985. doi: 10.1016/j.bmcl.2018.01.046. Epub 2018 Feb 9.

引用本文的文献

1
Quantum chemical modeling, molecular docking, and ADMET evaluation of imidazole phenothiazine hybrids.咪唑吩噻嗪杂化物的量子化学建模、分子对接及药物代谢动力学/药物毒性评价
Sci Rep. 2025 Jul 2;15(1):23413. doi: 10.1038/s41598-025-90495-1.
2
Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules.蛋白磷酸酶 2A（PP2A）的偏倚全酶组装：从癌症到小分子。
J Biol Chem. 2022 Dec;298(12):102656. doi: 10.1016/j.jbc.2022.102656. Epub 2022 Nov 1.
3
Direct activation of PP2A for the treatment of tyrosine kinase inhibitor-resistant lung adenocarcinoma.
直接激活 PP2A 治疗酪氨酸激酶抑制剂耐药的肺腺癌。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.125693.